{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:56:02Z","timestamp":1792014962741,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:00:00Z","timestamp":1550793600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10384-019-00656-9","type":"journal-article","created":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T01:45:15Z","timestamp":1550799915000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Clinical predictors of survival in metastatic uveal melanoma"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7545-7257","authenticated-orcid":false,"given":"Daniel","family":"Lorenzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Piulats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Ochoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Cobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Garcia-Bru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Padr\u00f3n-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Caminal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,22]]},"reference":[{"key":"656_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0039-6257(88)90173-7","volume":"32","author":"KM Egan","year":"1988","unstructured":"Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32:239\u201351.","journal-title":"Surv Ophthalmol."},{"key":"656_CR2","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, et al. Incidence of uveal melanoma in Europe. Ophthalmology. 2007;114:2309\u201315.","journal-title":"Ophthalmology."},{"key":"656_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/CMR.0b013e328353ef30","volume":"22","author":"JM Caminal","year":"2012","unstructured":"Caminal JM, Ribes J, Cl\u00e8ries R, Iba\u00f1ez N, Arias L, Piulats JM, et al. Relative survival of patients with uveal melanoma managed in a single center. Melanoma Res. 2012;22:271\u20137.","journal-title":"Melanoma Res."},{"key":"656_CR4","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/ijc.28625","volume":"134","author":"KD Bishop","year":"2014","unstructured":"Bishop KD, Olszewski AJ. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis. Int J Cancer. 2014;134:2961\u201371.","journal-title":"Int J Cancer."},{"key":"656_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","volume":"127","author":"C Shields","year":"2009","unstructured":"Shields C, Furuta M, Thangappan A, Nagori S, Mashayekhi A, Lally DR, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989\u201398.","journal-title":"Arch Ophthalmol."},{"key":"656_CR6","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2214\/ajr.157.6.1950883","volume":"157","author":"J Lorigan","year":"1991","unstructured":"Lorigan J, Wallace S, Mavligit G. The prevalence and location of metastases from ocular melanoma : imaging study in 110 patients. AJR AM J Roentgenol. 1991;157:1279\u201381.","journal-title":"AJR AM J Roentgenol."},{"key":"656_CR7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","volume":"123","author":"Group COMS","year":"2005","unstructured":"Group COMS. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma. Arch Ophthalmol. 2005;123:1639\u201343.","journal-title":"Arch Ophthalmol."},{"key":"656_CR8","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1002\/cam4.133","volume":"2","author":"K Buder","year":"2013","unstructured":"Buder K, Gesierich A, Gelbrich G, Goebeler M. Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives. Cancer Med. 2013;2:674\u201386.","journal-title":"Cancer Med."},{"key":"656_CR9","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1002\/cncr.28480","volume":"120","author":"SS Agarwala","year":"2014","unstructured":"Agarwala SS, Eggermont AMM, O\u2019Day S, Zager JS. Metastatic melanoma to the liver: a contemporary and comprehensive review of surgical, systemic, and regional therapeutic options. Cancer. 2014;120:781\u20139.","journal-title":"Cancer."},{"key":"656_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0161-6420(91)32285-1","volume":"98","author":"ES Gragoudas","year":"1991","unstructured":"Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, et al. Survival of patients with metastases from uveal melanoma. Ophthalmology. 1991;98:383\u20139.","journal-title":"Ophthalmology."},{"key":"656_CR11","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/cncr.11113","volume":"97","author":"S Eskelin","year":"2003","unstructured":"Eskelin S, Pyrh\u00f6nen S, Hahka-Kemppinen M, Tuomaala S, Kivel\u00e4 T. A prognostic model and staging for metastatic uveal melanoma. Cancer. 2003;97:465\u201375.","journal-title":"Cancer."},{"key":"656_CR12","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881\u20135.","journal-title":"Ophthalmology."},{"key":"656_CR13","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.ophtha.2013.12.014","volume":"121","author":"JW Harbour","year":"2014","unstructured":"Harbour JW, Chao DL. A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology. 2014;121:1281\u20138.","journal-title":"Ophthalmology."},{"key":"656_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0301-4738.154367","volume":"63","author":"S Kaliki","year":"2015","unstructured":"Kaliki S, Shields C, Shields J. Uveal melanoma: estimating prognosis. Indian J Ophthalmol. 2015;63:93\u2013102.","journal-title":"Indian J Ophthalmol."},{"key":"656_CR15","doi-asserted-by":"publisher","first-page":"e0120181","DOI":"10.1371\/journal.pone.0120181","volume":"10","author":"S Valpione","year":"2015","unstructured":"Valpione S, Moser J, Parrozzani R, Bazzi M, Mansfield S, Mocellin S, et al. Development and external validation of a prognostic nomogram for metastatic uveal melanoma. PLoS One. 2015;10:e0120181.","journal-title":"PLoS One."},{"key":"656_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ajo.2016.06.002","volume":"168","author":"T Kivel\u00e4","year":"2016","unstructured":"Kivel\u00e4 T, Piperno-Neumann, Desjardins L, Schmittel A, Bechrakis N, Midena E, et al. Validation of a prognostic staging for metastatic uveal melanoma: a collaborative study of the European ophthalmic oncology group. Am J Ophthalmol. 2016;168:217\u201326.","journal-title":"Am J Ophthalmol."},{"key":"656_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1001\/archopht.119.5.670","volume":"119","author":"Group COMS","year":"2001","unstructured":"Group COMS. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15. Arch Ophthalmol. 2001;119:670\u20136.","journal-title":"Arch Ophthalmol."},{"key":"656_CR18","doi-asserted-by":"crossref","unstructured":"Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. Malignant melanoma of the uvea. In: Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th edn. New York: Springer; 2010:547\u201359.","DOI":"10.1007\/978-0-387-88441-7_51"},{"key":"656_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/0197-2456(93)90052-F","volume":"14","author":"Group COMS","year":"1993","unstructured":"Group COMS. Design and methods of a clinical trial for a rare condition. Control Clin Trials. 1993;14:362\u201373.","journal-title":"Control Clin Trials."},{"key":"656_CR20","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1001\/archopht.124.12.1684","volume":"124","author":"Group COMS","year":"2006","unstructured":"Group COMS. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no. 28. Arch Ophthalmol. 2006;124:1684\u201393.","journal-title":"Arch Ophthalmol."},{"issue":"334\u201342","key":"656_CR21","first-page":"e1","volume":"156","author":"JM Caminal","year":"2013","unstructured":"Caminal JM, Mejia K, Masuet-Aumadell C, Arias L, Piulats JM, Guit\u00e9rrez C, et al. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Am J Ophthalmol. 2013;156(334\u201342):e1.","journal-title":"Am J Ophthalmol."},{"key":"656_CR22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/eye.2016.49","volume":"30","author":"JM Caminal","year":"2016","unstructured":"Caminal JM, Padr\u00f3n-P\u00e9rez N, Arias L, Masuet-Aumatell C, Guti\u00e9rrez C, Piulats JM, et al. Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma. Eye. 2016;30:833\u201342.","journal-title":"Eye."},{"key":"656_CR23","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1016\/j.ophtha.2003.02.001","volume":"110","author":"T Kivel\u00e4","year":"2003","unstructured":"Kivel\u00e4 T, Puusaari I, Damato B. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study. Ophthalmology. 2003;110:2235\u201344.","journal-title":"Ophthalmology."},{"key":"656_CR24","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1097\/IAE.0000000000000379","volume":"35","author":"J Garcia-Arumi","year":"2015","unstructured":"Garcia-Arumi J, Leila M, Zapata MA, Vel\u00e1zquez D, Dinares-Fernandez MC, Tresserra F, et al. Endoresection technique with\/without brachytherapy for management of high posterior choroidal melanoma: extended follow-up results. Retina. 2015;35:628\u201337.","journal-title":"Retina."},{"key":"656_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/1097-0142(19830715)52:2<334::AID-CNCR2820520225>3.0.CO;2-E","volume":"52","author":"S Rajpal","year":"1983","unstructured":"Rajpal S, Moore R, Karakousis C. Survival in metastatic ocular melanoma. Cancer. 1983;52:334\u20136.","journal-title":"Cancer."},{"key":"656_CR26","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1002\/1097-0142(19951101)76:9<1665::AID-CNCR2820760925>3.0.CO;2-J","volume":"76","author":"AY Bedikian","year":"1995","unstructured":"Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors. Cancer. 1995;76:1665\u201370.","journal-title":"Cancer."},{"key":"656_CR27","doi-asserted-by":"publisher","first-page":"8076","DOI":"10.1200\/JCO.2005.02.6534","volume":"23","author":"P Rietschel","year":"2005","unstructured":"Rietschel P, Panageas K, Hanlon C, Patel A, Abramson D, Chapman P. Variates of survival in metastatic uveal melanoma. J Clin Oncol. 2005;23:8076\u201380.","journal-title":"J Clin Oncol."},{"key":"656_CR28","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00417-005-1188-8","volume":"243","author":"L Kodjikian","year":"2005","unstructured":"Kodjikian L, Grange J-D, Baldo S, Baillif S, Garweg JG, Rivoire M. Prognostic factors of liver metastases from uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 2005;243:985\u201393.","journal-title":"Graefes Arch Clin Exp Ophthalmol."},{"key":"656_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/CMR.0b013e3283457726","volume":"21","author":"F Pons","year":"2011","unstructured":"Pons F, Plana M, Caminal JM, Pera J, Fernandes I, P\u00e9rez J, et al. Metastatic uveal melanoma. Melanoma Res. 2011;21:217\u201322.","journal-title":"Melanoma Res."},{"key":"656_CR30","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1200\/JCO.2004.08.194","volume":"22","author":"M Diener-West","year":"2004","unstructured":"Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Screening for metastasis from choroidal melanoma: The Collaborative Ocular Melanoma Study Group Report 23. J Clin Oncol. 2004;22:2438\u201344.","journal-title":"J Clin Oncol."},{"key":"656_CR31","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","volume":"122","author":"C Chattopadhyay","year":"2016","unstructured":"Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, et al. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer. 2016;122:2299\u2013312.","journal-title":"Cancer."},{"key":"656_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/sj.eye.6702322","volume":"21","author":"SA Callejo","year":"2007","unstructured":"Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye. 2007;21:752\u20139.","journal-title":"Eye."},{"key":"656_CR33","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/CMR.0b013e328357bea8","volume":"22","author":"PL Blanco","year":"2012","unstructured":"Blanco PL, Lim LA, Miyamoto C, Burnier MN. Uveal melanoma dormancy: an acceptable clinical endpoint? Melanoma Res. 2012;22:334\u201340.","journal-title":"Melanoma Res."},{"key":"656_CR34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrc3793","volume":"14","author":"MS Sosa","year":"2014","unstructured":"Sosa MS, Bragado P, Aguirre-Ghiso JA. Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer. 2014;14:611\u201322.","journal-title":"Nat Rev Cancer."},{"key":"656_CR35","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1151::AID-CNCR20>3.0.CO;2-G","volume":"85","author":"S Eskelin","year":"1999","unstructured":"Eskelin S, Pyrh\u00f6nen S, Summanen P, Prause J, Kivel\u00e4 T. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 1999;85:1151\u20139.","journal-title":"Cancer."},{"key":"656_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jamaophthalmol.2015.4810","volume":"134","author":"MM Choudhary","year":"2016","unstructured":"Choudhary MM, Gupta A, Bena J, Emch T, Singh AD. Hepatic ultrasonography for surveillance in patients with uveal melanoma. JAMA Ophthalmol. 2016;134:174\u201380.","journal-title":"JAMA Ophthalmol."},{"key":"656_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajo.2011.03.004","volume":"152","author":"JJ Augsburger","year":"2011","unstructured":"Augsburger JJ, Corr\u00eaa ZM, Trichopoulos N. Surveillance testing for metastasis from primary uveal melanoma and effect on patient survival. Am J Ophthalmol. 2011;152:5\u20139.","journal-title":"Am J Ophthalmol."},{"key":"656_CR38","first-page":"351","volume":"31","author":"K Hendler","year":"2011","unstructured":"Hendler K, Pe\u2019er J, Kaiserman I, Baruch R, Kalickman I, Barak V, et al. Trends in liver function tests: a comparison with serum tumor markers in metastatic uveal melanoma (part 2). Anticancer Res. 2011;31:351\u20137.","journal-title":"Anticancer Res."},{"key":"656_CR39","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.ophtha.2012.01.045","volume":"119","author":"F Mouriaux","year":"2012","unstructured":"Mouriaux F, Diorio C, Bergeron D, Berchi C, Rousseau A. Liver function testing is not helpful for early diagnosis of metastatic uveal melanoma. Ophthalmology. 2012;119:1590\u20135.","journal-title":"Ophthalmology."},{"key":"656_CR40","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00432-014-1804-2","volume":"141","author":"LL Chen","year":"2015","unstructured":"Chen LL, Tian JJ, Su L, Jing Y, Zhang SC, Zhang HX, et al. DJ-1: a promising marker in metastatic uveal melanoma. J Cancer Res Clin Oncol. 2015;141:315\u201321.","journal-title":"J Cancer Res Clin Oncol."},{"key":"656_CR41","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ajo.2003.08.045","volume":"137","author":"I Kaiserman","year":"2004","unstructured":"Kaiserman I, Amer R, Pe\u2019Er J. Liver function tests in metastatic uveal melanoma. Am J Ophthalmol. 2004;137:236\u201343.","journal-title":"Am J Ophthalmol."},{"key":"656_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/cncr.11872","volume":"100","author":"EC Hsueh","year":"2004","unstructured":"Hsueh EC, Essner R, Foshag LJ, Ye X, Wang H-J, Morton DL. Prolonged survival after complete resection of metastases from intraocular melanoma. Cancer. 2004;100:122\u20139.","journal-title":"Cancer."},{"key":"656_CR43","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1136\/bjo.2008.153684","volume":"93","author":"S Frenkel","year":"2009","unstructured":"Frenkel S, Nir I, Hendler K, Lotem M, Eid A, Jurim O, et al. Long-term survival of uveal melanoma patients after surgery for liver metastases. Br J Ophthalmol. 2009;93:1042\u20136.","journal-title":"Br J Ophthalmol."},{"key":"656_CR44","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ajo.2015.11.019","volume":"162","author":"ZM Corr\u00eaa","year":"2016","unstructured":"Corr\u00eaa ZM, Augsburger JJ. Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas. Am J Ophthalmol. 2016;162:20\u20137.","journal-title":"Am J Ophthalmol."},{"key":"656_CR45","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jamaophthalmol.2016.0913","volume":"134","author":"S Walter","year":"2016","unstructured":"Walter S, Chao D, Feuer W, Schiffman J, Chan D, Harbour J. Prognostic implications of tumor diameter in association with gene expression profile for uveal melanoma. JAMA Ophthalmol. 2016;134:734\u201340.","journal-title":"JAMA Ophthalmol."}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10384-019-00656-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-019-00656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-019-00656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T19:23:48Z","timestamp":1582313028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10384-019-00656-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,22]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1007\/s10384-019-00656-9","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,22]]},"assertion":[{"value":"29 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D. Lorenzo, None; J. M. Piulats, None; M. Ochoa, None; L. Arias, None; C. Guti\u00e9rrez, None; J. Catal\u00e0, None; E. Cobos, None; P. G. -Bru, None; B. Dias, None; N. P. -P\u00e9rez, None; J. M. Caminal, None.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}